L2-01 for recently diagnosed Crohn's disease in remission
Part of Digestive system clinical trials.
This trial tests a new treatment called L2-01 for people who were recently diagnosed with Crohn's disease and whose disease is currently in remission. The goal is to see if it can help prevent flares and keep you feeling well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with Crohn's disease within the last 12 months.
- Your Crohn's disease should be in remission (not active), with a CDAI score of 200 or less.
- You must be at least 18 years old.
- You cannot have used infliximab or any other anti-TNF drug in the last 8 weeks.
- You cannot have used tacrolimus or cyclosporine in the last 4 weeks.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
This trial tests an experimental drug for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The drug aims to reduce inflammation and may help improve symptoms.
This trial tests whether a type of stem cell called HB-adMSCs can help treat Crohn's disease. It is for adults with mild to moderate Crohn's who have certain signs of inflammation in their blood and recent imaging of their condition.
This study tests injections of stem cells placed directly into Crohn’s affected tissue. It may help people whose Crohn’s disease lesions have not responded to standard medicines and biologic therapies.
This trial studies whether an “autologous” stem cell transplant (using your own cells) can improve Crohn’s disease that has not responded to standard treatments. It may help people who have ongoing, hard-to-control Crohn’s even after medicines and/or who have complications that make surgery risky.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
Hear when a new Crohn&Amp;#39;s trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.